SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-057516
Filing Date
2023-05-09
Accepted
2023-05-09 09:03:32
Documents
16
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315123d1_8k.htm   iXBRL 8-K 25410
2 EXHIBIT 99.1 tm2315123d1_ex99-1.htm EX-99.1 31185
6 GRAPHIC tm2315123d1_ex99-1img1.jpg GRAPHIC 4039
7 GRAPHIC tm2315123d1_ex99-1img2.jpg GRAPHIC 95935
8 GRAPHIC tm2315123d1_ex99-1img3.jpg GRAPHIC 48840
  Complete submission text file 0001104659-23-057516.txt   441962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20230509.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20230509_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20230509_pre.xml EX-101.PRE 22593
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2315123d1_8k_htm.xml XML 3494
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 23900217
SIC: 2834 Pharmaceutical Preparations